National Asset Management, Inc. Assembly Biosciences, Inc. Transaction History

National Asset Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$15.08 - $27.04 $209,612 - $375,856	-13,900 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$14.57 - $23.96 $14,570 - $23,960	-1,000 Reduced 6.71%	13,900 $325,000
Q1 2020 May 06, 2020	SELL	$10.27 - $21.23 $2,054 - $4,246	-200 Reduced 1.32%	14,900 $221,000
Q4 2019 Feb 10, 2020	BUY	$8.36 - $23.81 $126,235 - $359,531	15,100 New	15,100 $309,000
Q2 2019 Aug 05, 2019	SELL	$12.9 - $20.8 $155,445 - $250,640	-12,050 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$17.7 - $24.93 $11,593 - $16,329	-655 Reduced 5.16%	12,050 $238,000
Q4 2018 Feb 08, 2019	SELL	$19.05 - $36.45 $95,250 - $182,250	-5,000 Reduced 28.24%	12,705 $288,000
Q3 2018 Nov 08, 2018	SELL	$34.41 - $44.23 $58,496 - $75,191	-1,700 Reduced 8.76%	17,705 $658,000
Q2 2018 Oct 05, 2018	BUY	$39.21 - $50.29 $187,227 - $240,134	4,775 Added 32.64%	19,405 $761,000
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $610,071 - $938,660	14,630 New	14,630 $719,000
Q4 2017 Feb 15, 2018	SELL	$28.58 - $49.91 $252,932 - $441,703	-8,850 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$23.08 - $34.92 $56,545 - $85,554	-2,450 Reduced 21.68%	8,850 $310,000
Q2 2017 Aug 15, 2017	BUY	N/A	11,300	11,300 $234,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $737M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.